StonvexLoading…
StonvexStonvexStonvexCore line items from BVS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $568.09M | $573.28M | $512.35M | $512.12M |
Operating Income | $53.98M | $-15.20M | $-81.72M | $-167.23M |
Net Income | $22.73M | $-36.13M | $-156.23M | $-158.70M |
EPS (Diluted) | $0.33 | $-0.56 | $-2.49 | $-2.59 |
Total Assets | $683.56M | $727.96M | $810.91M | $1.37B |
Total Liabilities | $455.11M | $542.35M | $589.79M | $960.43M |
Cash & Equivalents | $51.24M | $41.58M | $36.96M | $30.19M |
Free Cash Flow OCF − CapEx | $72.11M | $37.79M | $7.98M | $-15.02M |
Shares Outstanding | 68.91M | 64.55M | 62.65M | 61.39M |